- Home
- LFT vs SRTS Comparison
LFT vs SRTS Comparison
Compare LFT & SRTS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | LFT | SRTS |
|---|---|---|
| Founded | 2012 | 2010 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Real Estate Investment Trusts | Medical/Dental Instruments |
| Sector | Real Estate | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 75.4M | 79.3M |
| IPO Year | N/A | 2016 |
Fundamental Metrics
Financial Performance| Metric | LFT | SRTS |
|---|---|---|
| Price | $1.34 | $5.06 |
| Analyst Decision | Hold | Strong Buy |
| Analyst Count | 1 | 3 |
| Target Price | N/A | ★ $8.00 |
| AVG Volume (30 Days) | ★ 234.8K | 124.5K |
| Earning Date | 03-18-2026 | 02-10-2026 |
| Dividend Yield | ★ 11.94% | N/A |
| EPS Growth | N/A | ★ N/A |
| EPS | ★ 0.09 | N/A |
| Revenue | $21,708,246.00 | ★ $35,609,000.00 |
| Revenue This Year | $124.75 | N/A |
| Revenue Next Year | N/A | $29.12 |
| P/E Ratio | $14.23 | ★ N/A |
| Revenue Growth | N/A | ★ N/A |
| 52 Week Low | $1.30 | $3.03 |
| 52 Week High | $2.84 | $9.08 |
Technical Indicators
Market Signals| Indicator | LFT | SRTS |
|---|---|---|
| Relative Strength Index (RSI) | 39.66 | 63.03 |
| Support Level | $1.44 | $4.64 |
| Resistance Level | $1.46 | $5.36 |
| Average True Range (ATR) | 0.05 | 0.38 |
| MACD | -0.01 | 0.00 |
| Stochastic Oscillator | 2.18 | 64.62 |
Price Performance
Historical ComparisonAbout LFT Lument Finance Trust Inc.
Lument Finance Trust Inc operates as a real estate investment trust. The company is engaged in investment, financing, and management of a portfolio of commercial real estate debt investments. It invests in transitional floating-rate commercial real estate mortgage loans, mezzanine loans, preferred equity, commercial mortgage-backed securities, fixed-rate loans, construction loans, and other CRE debt instruments.
About SRTS Sensus Healthcare Inc.
Sensus Healthcare Inc is engaged in manufacturing a superficial radiotherapy system. These devices are used for treating both oncological and non-oncological skin conditions including basal cell and squamous cell skin cancers and other skin conditions such as keloids. Its product includes SRT-100, SRT-100 vision, and a sentinel service program. The company's revenue is generated majorly from customers in the United States.